Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study (Q38442025)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2005

Language	Label	Description	Also known as
English	Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study	scientific article published on September 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ovarian carcinoma

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

author name string

Hermann Brustmann

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

396-402

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Telomeres shorten during ageing of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Significance of immunological detection of human telomerase reverse transcriptase: re-evaluation of expression and localization of human telomerase reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

C-kit immunoreactivity in endometrial adenocarcinomas and its clinicopathologic significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Human telomerase reverse transcriptase mRNA expression assessed by real-time reverse transcription polymerase chain reaction predicts chemosensitivity in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

A genetically defined model for human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Telomerase in breast cancer: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.035

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.04.035

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38442025&oldid=2165755330"